Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across the Blood−Brain Barrier and Aβ Fibril Disaggregation-Reference-Cited by-同舟云学术

Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across the Blood−Brain Barrier and Aβ Fibril Disaggregation

Published:2007-02-22 Issue:2 Volume:18 Page:447-455
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Boado Ruben J.¹,Zhang Yufeng¹,Zhang Yun¹,Xia Chun-Fang¹,Pardridge William M.¹

Affiliation:

1. ArmaGen Technologies, Incorporated, 914 Colorado Avenue, Santa Monica, California, and Department of Medicine, University of California at Los Angeles, Los Angeles, California

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc060349x

Reference34 articles.

1. Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations

2. Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring How Antibody Format Drives Clearance from the Brain;Molecular Pharmaceutics;2024-07-26

2. Selective Uptake of Macromolecules to the Brain in Microfluidics and Animal Models Using the HAVN1 Peptide as a Blood-Brain Barrier Modulator;Molecular Pharmaceutics;2024-02-23

3. Design and preparation of naringenin loaded functional biomimetic nano-drug delivery system for Alzheimer’s disease;Journal of Drug Targeting;2023-12-12

4. Exit pathways of therapeutic antibodies from the brain and retention strategies;iScience;2023-11

5. Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery;Journal of Nanotheranostics;2023-10-02